Key result
Microfluidic cardiac biomarker biosensors show point-of-care promise but require multidisciplinary collaboration for clinical translation.
This review examines the current state of the art lab-on-a-chip and microfluidic based biosensor technologies used in the detection of cardiac biomarkers. The determination and quantification of blood based, cardiac biomarkers are crucial in the triage and management of a range of cardiac related conditions, where time delay has a major impact on short and longer-term outcomes of a patient. The design and manufacturing of biomarker detection systems are multi-disciplinary in nature and require researchers to have knowledge of both life sciences and engineering for the full potential of this field to be realised. This review will therefore provide a comprehensive overview of chip based immunosensing technology as applied to cardiac biomarker detection, while discussing the potential suitability and limitations of each configuration for incorporation within a clinical diagnostics device suitable for point-of-care applications.
No takes yet. Share an insight, caveat, or question.
Mohammed et al. (2010) conducted a review in Cardiac conditions. Lab-on-a-chip and microfluidic-based biosensors was evaluated. Lab-on-a-chip and microfluidic-based biosensors offer promising potential for point-of-care cardiac biomarker detection but require multidisciplinary expertise for clinical incorporation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: